ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "systemic lupus erythematosus (SLE) and women’s health"

  • Abstract Number: 1642 • 2017 ACR/ARHP Annual Meeting

    Role of Plaque in Predicting Cardiovascular Events in Women with Lupus over a 20 Year Followup

    Erika Joyce1, Linda Santelices2, Jennifer Mall2, Kristy Huysman2, Amy Xiaoqin Tang3, Michael Anderson2, Jennifer Elliott4, Amy H. Kao5,6 and Susan Manzi2, 1Internal Medicine, Allegheny Health Network, Pittsburgh, PA, 2Medicine, Allegheny Health Network, Pittsburgh, PA, 3Lupus Center of Excellence, Allegheny Health Network Research Institute, Pittsburgh, PA, 4Allegheny Health Network, Pittsburgh, PA, 5EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA, 6EMD Serono Research & Development Institute, Inc. (a business of Merck KGaA), Billerica, MA

    Background/Purpose: The increased risk of premature cardiovascular disease (CVD) in systemic lupus erythematosus (SLE) patients has been well reported. Multiple series have demonstrated a higher…
  • Abstract Number: 2439 • 2016 ACR/ARHP Annual Meeting

    Effect of Pregnancy Counseling on the Outcome of Pregnancies in Women with Systemic Lupus Erythematosus: A Prospective Observational Study

    Rebecca Fischer-Betz1, Lisa Kueppers2, Ralph Brinks2, Oliver Sander3, Christof Specker4 and Matthias Schneider3, 1Policlinic of Rheumatology and Hiller Research Unit Rheumatology, Heinrich-Heine University, Duesseldorf, Duesseldorf, Germany, 2Department of Rheumatology&Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 3Department of Rheumatology & Hiller Research Unit, Heinrich-Heine-University, Duesseldorf, Germany, 4Rheumatology and Clinical Immunology, Kliniken Essen Sued, Essen, Germany

    Background/Purpose: Pregnancies in women with systemic lupus erythematosus (SLE) are associated with increased frequencies of adverse pregnancy outcomes (APOs). Preconception counseling including risk stratification and…
  • Abstract Number: 2237 • 2012 ACR/ARHP Annual Meeting

    Application and Feasibility of Proposed Systemic Lupus Erythematosus Reproductive Health Care Quality Indicators At a Public Urban Rheumatology Clinic

    Itziar Quinzanos1, Angela Keniston2, Joann Zell3, Jinoos Yazdany4, Alyssa Nash1, Rebecca Fransen1, Jennifer Stichman1 and Joel M. Hirsh5, 1Dept Medicine, Denver Health Med Ctr, Denver, CO, 2Department of Medicine, Denver Health and Hospital Authority, Denver, CO, 3Medicine, National Jewish Health, Denver, CO, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO

    Background/Purpose: Reproductive health quality indicators (QIs) for systemic lupus erythematosus (SLE) have recently been developed: anti-ssA, anti-ssB, and phospholipid antibody (aPL) screening prior to pregnancy;…
  • Abstract Number: 655 • 2012 ACR/ARHP Annual Meeting

    Non-White Race, Younger Age, and Use of Primary and Gynecologic Care Are Associated with Higher Rates of Cervical Cancer Screening in Systemic Lupus Erythematosus Patients At a Public Hospital

    Jennifer Stichman1, Angela Keniston2, Joann Zell3, Jinoos Yazdany4, Itziar Quinzanos1 and Joel M. Hirsh5, 1Dept Medicine, Denver Health Med Ctr, Denver, CO, 2Department of Medicine, Denver Health and Hospital Authority, Denver, CO, 3Medicine, National Jewish Health, Denver, CO, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO

    Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at increased risk of cervical dysplasia and persistent Human Papilloma Virus (HPV) infection. There are few prior…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology